Advertisement
Screener

Arno Therapeutics, Inc Interest Expense

Arno Therapeutics, Inc Interest Expense

Arno Therapeutics, Inc reported Interest Expense of $214 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2016-11-14

  • Arno Therapeutics, Inc interest expense for the quarter ending 2016-09-30 was $214.00, a 38.68% decline year-over-year.
  • Arno Therapeutics, Inc interest expense for the quarter ending 2016-06-30 was $250.00, a 34.21% decline year-over-year.
  • Arno Therapeutics, Inc interest expense for the quarter ending 2016-03-31 was $14.52K, a 3440.98% increase year-over-year.
  • Arno Therapeutics, Inc interest expense for the quarter ending 2015-12-31 was $27.26K, a 18965.73% increase year-over-year.
  • Arno Therapeutics, Inc interest expense for fiscal 2015 was $28.40K, a 19762.24% increase from fiscal 2014.
  • Arno Therapeutics, Inc interest expense for fiscal 2014 was $143.00, a 100.00% decline from fiscal 2013.
  • Arno Therapeutics, Inc interest expense for fiscal 2013 was $18.57M, a 191.92% increase from fiscal 2012.
  • Arno Therapeutics, Inc interest expense for fiscal 2012 was $6.36M.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 monthInterest Expense 71 monthInterest Expense 74 monthInterest Expense 77 monthInterest Expense 80 monthInterest Expense 83 monthInterest Expense 86 monthInterest Expense 89 monthInterest Expense 92 monthInterest Expense 95 monthInterest Expense 98 monthInterest Expense 101 monthInterest Expense 104 monthInterest Expense 107 month
2016-09-30$214.00
10-Q · filed 2016-11-14
$464.00
derived: sum of 2 quarters · filed 2016-11-14
$14.98K
10-Q · filed 2016-11-14
$42.25K
derived: sum of 4 quarters · filed 2016-11-14
2016-06-30$250.00
10-Q · filed 2016-08-22
$14.77K
10-Q · filed 2016-08-22
$42.03K
derived: sum of 3 quarters · filed 2016-08-22
$42.38K
derived: sum of 4 quarters · filed 2016-11-14
2016-03-31$14.52K
10-Q · filed 2016-05-16
$41.78K
derived: sum of 2 quarters · filed 2016-05-16
$42.13K
derived: sum of 3 quarters · filed 2016-11-14
$42.51K
derived: sum of 4 quarters · filed 2016-11-14
2015-12-31$27.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$27.61K
derived: sum of 2 quarters · filed 2016-11-14
$27.99K
derived: sum of 3 quarters · filed 2016-11-14
$28.40K
10-K · filed 2016-03-30
2015-09-30$349.00
10-Q · filed 2016-11-14
$729.00
derived: sum of 2 quarters · filed 2016-11-14
$1.14K
10-Q · filed 2016-11-14
$1.28K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$380.00
10-Q · filed 2016-08-22
$790.00
10-Q · filed 2016-08-22
$933.00
derived: sum of 3 quarters · filed 2016-08-22
$933.00
derived: sum of 4 quarters · filed 2016-08-22
2015-03-31$410.00
10-Q · filed 2016-05-16
$553.00
derived: sum of 2 quarters · filed 2016-05-16
$553.00
derived: sum of 3 quarters · filed 2016-05-16
$553.00
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$143.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$143.00
derived: sum of 2 quarters · filed 2016-03-30
$143.00
derived: sum of 3 quarters · filed 2016-03-30
$143.00
10-K · filed 2016-03-30
2014-09-30$0.00
10-Q · filed 2015-11-16
$0.00
derived: sum of 2 quarters · filed 2015-11-16
$0.00
10-Q · filed 2015-11-16
$12.69M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$0.00
10-Q · filed 2015-08-14
$0.00
10-Q · filed 2015-08-14
$12.69M
derived: sum of 3 quarters · filed 2015-08-14
$14.55M
derived: sum of 4 quarters · filed 2015-08-14
$26.19M
10-Q · filed 2014-08-14
2014-03-31$0.00
10-Q · filed 2015-05-15
$12.69M
derived: sum of 2 quarters · filed 2015-05-15
$14.55M
derived: sum of 3 quarters · filed 2015-05-15
$16.41M
derived: sum of 4 quarters · filed 2015-05-15
$26.19M
10-Q · filed 2014-05-15
2013-12-31$12.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$14.55M
derived: sum of 2 quarters · filed 2015-03-31
$16.41M
derived: sum of 3 quarters · filed 2015-03-31
$18.57M
10-K · filed 2015-03-31
$26.19M
10-K · filed 2014-03-31
2013-09-30$1.86M
10-Q · filed 2014-11-14
$3.72M
derived: sum of 2 quarters · filed 2014-11-14
$5.88M
10-Q · filed 2014-11-14
$12.24M
derived: sum of 4 quarters · filed 2014-11-14
$13.50M
10-Q · filed 2013-11-14
2013-06-30$1.86M
10-Q · filed 2014-08-14
$4.02M
10-Q · filed 2014-08-14
$10.38M
derived: sum of 3 quarters · filed 2014-08-14
$10.38M
derived: sum of 4 quarters · filed 2014-08-14
$11.64M
10-Q · filed 2013-08-14
2013-03-31$2.16M
10-Q · filed 2014-05-15
$8.52M
derived: sum of 2 quarters · filed 2014-05-15
$8.52M
derived: sum of 3 quarters · filed 2014-05-15
$8.52M
derived: sum of 4 quarters · filed 2014-05-15
$9.78M
10-Q · filed 2013-05-15
2012-12-31$6.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$6.36M
derived: sum of 2 quarters · filed 2014-03-31
$6.36M
derived: sum of 3 quarters · filed 2014-03-31
$6.36M
10-K · filed 2014-03-31
$7.62M
10-K · filed 2013-04-01
2012-09-30$0.00
10-Q · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
10-Q · filed 2013-11-14
$1.26M
10-Q · filed 2012-11-19
2012-06-30$0.00
10-Q · filed 2013-08-14
$0.00
derived: sum of 2 quarters · filed 2013-08-14
$1.26M
10-Q/A · filed 2012-09-07
2012-03-31$0.00
10-Q · filed 2013-05-15
$1.26M
10-Q · filed 2012-05-15
2011-12-31$0.00
10-K · filed 2013-04-01
$1.26M
10-K · filed 2012-03-30
2011-09-30$1.26M
10-Q · filed 2011-11-14
2011-06-30$1.26M
10-Q · filed 2011-08-15